BGI Genomics Announces Pricing of Initial Public Offering

General Press Releases Friday July 14, 2017 15:45
SHENZHEN, China--14 Jul--PRNewswire/InfoQuest
BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share.
BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. The shares began trading on July 14 under the code 300676.
The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017.

For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. The event marks a major step for BGI Genomics towards realizing its vision of "Trans-omics for a better life."

"In the genomics field, we aim to dominate the market, creating a bright future for all by bringing both social and economic benefits," BGI Genomics' President Wang Jian said in his opening statement at the IPO ceremony. "Benefitting from our innovations in scientific research, the industry will become more active; by serving people's lives as the starting point, the industry will also become more competitive and scalable." Wang, who co-founded BGI Group in 1999, vowed not to sell any of his holdings in the next five years, adding he would remain invested over the long term to drive the goal of reducing gene-related disabilities in China.

"This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. "The capital raised will allow us to invest in the development of new services, top talent and lab infrastructure to benefit our global customers and to support our continued growth and innovation."

About BGI Genomics

BGI Genomics is a part of BGI Group, one of the world's largest genomics organizations. BGI Group was founded in 1999 with the vision of using genomics to benefit humanity and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI Group has a proven track record of innovative, high profile research, which has generated over 2,000 publications.

BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics' mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions that are available for everybody.

BGI Genomics has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research. Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI Genomics' world leading bio-informatics research and development, large scale computing infrastructure and proprietary sequencing platforms.

BGI Genomics is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI Genomics also has offices and laboratories located in Europe, North America and the Asia Pacific region.

For more information: www.bgi.com/global/
For Commercial Queries:
Matt Poulter
Global Marketing Manager
matt.poulter@bgi.com
Photo - https://photos.prnasia.com/prnh/20170714/1899281-1
Caption - Announces launch of IPO

Latest Press Release

THE FORESTIAS launches #Forest Rescue a large-scale operation to save trees in and around Bangkok

Magnolia Quality Development Corporation Limited (MQDC), represented by Mrs. Sasinan Allmand (First picture : 2nd from left), Executive Vice President, Corporate Marketing and Communications; Mr. Kittiphun Ouiyamaphun (First picture : 1st from left),...

Pamper yourself at home with the touch of Spa Cenvaree with our new range of retail products

Take home some of the signature scents and aromas of the award-winning Spa Cenvaree with our range of newly released range of retail products – all available to purchase at our 26th-floor location at Centara Grand at CentralWorld. From hand creams...

Photo Release: BSH, Boonthavorn Make Debut of #Bosch Shop to Allure Premium Customers in Kaset-Nawamin Community

Recently, Mr. Chollawit Na Songkhla, Managing Director, BSH Home Appliances Company Ltd., Thailand (left) teamed up with Mr. Sapasit Leelasornchai, General Manager − Kitchen Business Section of Boonthavorn Ceramics Co., Ltd (right) to announce the...

Throughout July 2018, experience the pleasures of our award-winning Le SPA with L#Occitane.

Throughout July 2018, experience the pleasures of our award-winning Le SPA with L'Occitane. Pamper Early Bird Package (60 minutes) Enjoy Rejuvenating Body Wrap and Head Massage for THB 2,300 ++ Available daily from 10.00-16.00 hrs. Stress Release Package...

Toshiba Thailand Plans to Be More Proactive In the Second Half of 2018 With More Than 34 New Products Line Up, Expecting 2-digit Revenue Growth

Mr. Toshiro Ishiwatari, Chairman of Toshiba Lifestyle Products and Services Corporation (TLSC), Japan, along with Mr. Brian Zhao, President of Toshiba Thailand Co. Ltd., and top management team, held a press conference on "A New Chapter Beyond All...

Related Topics